Although the studies were not uniform in design, all reported that weight loss, improved glycemic control, and hepatic steatosis were associated with varying degrees with serum C-reactive protein (CRP) reduction (Kuryłowicz and Koźniewski, 2020). Here, CRP is linked to fatty liver disease.